Download PDF
Open Access
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2007; 28(01): 4-5
DOI: 10.1055/s-0041-1733195
Editorial

Neoadjuvant Chemotherapy for Advanced Ovarian Cancer

Authors

  • Roopa Hariprasad

    Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi-110029, India

  • L Kumar

    Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi-110029, India

  • Col.A Kapoor

    Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi-110029, India
Further Information
Also available at
 PDF Download Permissions and Reprints
Preview Container


Publication History

Article published online:
23 March 2022

© 2007. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
  • 2 Meyer JI, Kennedy AW, Friedman R, et al. Ovarian carcinoma: value of CT in predicting success of debulking surgery. Am J Roentgenol. 1995;165(4):875- 8.
  • 3 Sharma S, Vijay Kumar DK, Chitrathara K et al. Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A retrospective study. Ind J Med & Paed Oncol 2007;28:7-13.
  • 4 Kuhn W, Rutke S, Spathe K, et al. Neoadjuvant chemotherapy followed by tumour debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma. Cancer 2001;92:2585–2591.
  • 5 Bristow RE and Chi DS. Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis. Gynecol Oncol. 2006;103(3):1070-6.
  • 6 Kumar L, Hariprasad R, Kumar S, et al. J.Clin.Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No.18S (Supplement), 2006:15000.